Epigenetic and post-translational modifications in ferroptosis regulation and hepatocellular carcinoma: New frontiers in therapeutic targeting
Pathology - Research and Practice · 2025
DOI: 10.1016/j.prp.2025.155991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Soheil Bolandi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Protein Processing, Post-Translational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 170 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), the predominant kind of liver cancer, continues to be a significant contributor to cancer-related deaths globally, influenced by intricate molecular processes and strong resistance to existing chemotherapy. Iron-dependent lipid peroxidation induces ferroptosis, a controlled form of cell death that plays a crucial role in inhibiting tumor growth and treatment resistance in HCC. Recent research has shown that epigenetic modifications, such as DNA methylation, histone modifications, regulation by non-coding RNAs (ncRNAs), and post-translational modification (PTM) like ubiquitination, phosphorylation, acetylation, and methylation, play a crucial role in fine-tuning ferroptosis. These alterations alter the structure of chromatin, gene expression, and protein function, thereby affecting cancer cells' fate. This review emphasizes the complex functions of epigenetic and post-translational alterations in controlling ferroptosis, providing valuable insights into their potential as therapeutic targets in HCC. The unraveling of these pathways offers a significant opportunity for novel therapies targeted at surmounting drug resistance and enhancing patient outcomes in liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
- School of Pharmacy, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Department of Medical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Medical Microbiology, College of Health Sciences, Cihan University Sulaimaniya, Sulaimaniya City, Kurdistan, Iraq.
- Department of Adult Hematology & Oncology, School of Medicine, Ayatollah Khansari Hospital, Arak University of Medical Sciences, Arak, Iran.
- Department Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Bolandi, S., Dodge, S., Zahed, Z., Soleimani, A., Monirvaghefi, K., Ghodsifar, M., Ghasemi, M., Aghajamal Avval, N., Zadeh, S. S. M., Fazayel, S. M. A., Morovatshoar, R., Barfi, V., Behfar, Q., & Dehghani, S. (2025). Epigenetic and post-translational modifications in ferroptosis regulation and hepatocellular carcinoma: New frontiers in therapeutic targeting. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155991
Vancouver
Bolandi S, Dodge S, Zahed Z, Soleimani A, Monirvaghefi K, Ghodsifar M, et al. Epigenetic and post-translational modifications in ferroptosis regulation and hepatocellular carcinoma: New frontiers in therapeutic targeting. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155991
BibTeX
@article{Bolandi2025,
author = {Bolandi, Soheil and Dodge, Samaneh and Zahed, Zahra and Soleimani, Anvar and Monirvaghefi, Khaterehsadat and Ghodsifar, Mahshid and Ghasemi, Moein and Aghajamal Avval, Nahal and Zadeh, Seyedeh Sahar Mojtaba and Fazayel, Seyed Mohammad Ali and Morovatshoar, Reza and Barfi, Vahid and Behfar, Qumars and Dehghani, Sima},
title = {Epigenetic and post-translational modifications in ferroptosis regulation and hepatocellular carcinoma: New frontiers in therapeutic targeting},
journal = {Pathology - Research and Practice},
year = {2025},
doi = {10.1016/j.prp.2025.155991}
}
EUVIMED